Motor neuron disease usually refers to amyotrophic lateral sclerosis, but it can also refer to other kind of neurodegenerative disease that affect the motor neurons, such as progressive primary ...
Baron Discovery Fund highlighted stocks like Axon Enterprise, Inc. (NASDAQ:AXON), in the fourth quarter 2024 investor letter. Axon Enterprise, Inc. (NASDAQ:AXON) manufacturers conducted energy ...
Among last year's top gainers was Axon Enterprise (NASDAQ: AXON), which makes tech-based software and hardware for the law enforcement and public safety industries. Axon has been a winning stock ...
U.S. Ski and Snowboard has partnered with Ski Austria to develop commercial and sport performance opportunities, marking the first time the national governing body has formed an official partnership ...
The Canyon Neuron has long been the German brand’s most approachable do-it-all trail bike. Sitting in between the lightweight Lux Trail and the bigger travel Spectral, the Neuron aims to strike a ...
Discover how the new Axon SkySwap Program can help your agency transition to NDAA-compliant, American-made and autonomous drone solutions. This initiative offers discounts on secure hardware, software ...
Neuron Energy, a leading electric vehicle (EV) battery manufacturer, inaugurated a new 5-acre manufacturing facility in Chakan, Pune, during the Bharat Mobility Global Expo 2025. The state-of-the ...
Axon (AXON) stock was one of 2024’s major winners. Shares of the nonlethal weapons company posted a scorching 167% return for the year, and the stock joined the Nasdaq-100, an influential index ...
Axon delivered impressive growth throughout 2024, beating estimates and raising its guidance. The company expanded its total addressable market through acquisitions. It introduced a new generative ...
Their findings, published in Neuron, suggest that the two systems interact in the hippocampus, with persistent WM activity predicting the formation of LTM. "Working memory (WM) and long-term ...
Image source: Axon. What to expect for Axon in 2025 Axon's valuation could put pressure on the stock this year because it currently trades at a price-to-earnings ratio of 150 and a price-to-sales ...